Table 1. MiR-210 expression and clinicaopathological feature in BC patients [median (interquartile range)].

Clinicopathological feature	NO. of cases	miR-210 expression	P
Gender			0.475 a
Male	128	58.680 (39.110–72.473)
Female	40	54.360 (31.440–89.780)
Age c			0.438 a
Under 65	74	57.260 (39.350–74.128)
65 or more	94	56.990 (37.043–72.263)
Grade			0.058 b
G1	48	50.620 (31.513–69.203)
G2	50	54.785 (37.048–69.523)
G3	70	61.890 (42.170–76.770)
T stage			0.000 a
Ta–T1	84	45.805(30.023–60.478)
T2–T4	84	69.025 (54.336–85.915)
N stage			0.081 a
N0	146	56.435 (38.378–69.780)
N1-3	22	72.315 (37.613–116.763)
M stage			0.040 a
M0	154	56.285 (38.298–71.558)
M1-3	14	71.390 (58.233–88.020)

^aStatistical significance was determined by the Kruskal-Wallis test.

^bStatistical significance was determined by the Mann-Whitey U test.

^c The mean age of the patients is 64.8.